Laura Powell, PhD
Life science consultant specializing in vaccines and antibody development
Houston, Texas
Summary
Experienced life-science consultant who combines domain expertise in biologics with government-focused proposal and program management. everglade+1
Technical background in monoclonal antibody discovery and characterization from doctoral work in the Crowe lab, including neutralization assays, ELISAs, epitope binning, and mechanistic studies against alphaviruses. vumc+1
Project management credentials and experience: earned PMP certification in 2022 and has supported preclinical/clinical development programs, post-award management, and multi-agency proposal efforts for BARDA, DARPA, NIH, DTRA, and JPEO. everglade+1
Strong science communication and collaborative skills demonstrated by manuscript contributions, conference presentations, scholarship awards (e.g., Keystone Symposia Future of Science Fund), and authorship of technical/government funding-focused blog posts. vumc+2
Work
Education
Projects
Writing
A novel proposal: antibody treatment for AFM (symposium materials)
January 1, 2020Symposium presentation/materials (AFM symposium) listing Laura Powell among contributors, discussing antibody-based approaches for acute flaccid myelitis.
ARPA-H THRIVE ISO Amendment 1 (EverGlade blog post)
EverGlade blog post summarizing Amendment No. 1 for ARPA-H's THRIVE initiative and implications for applicants and funding opportunities.
DTRA Funding Novel Technologies and Medical Countermeasures (EverGlade blog post)
EverGlade blog post summarizing a DTRA amendment and funding opportunities for novel technologies and medical countermeasures against WMD and emerging threats.